                                                                                             0                1
                                                    The application was received by the EMA on      3 June 2019
                                                                      The procedure started on     20 June 2019
The CHMP Rapporteur's first Assessment Report was circulated to all \nCHMP and PRAC members on 9 September 2019
                                                                                                                                                                    0                 1
                                                                       The PRAC Rapporteur's first Assessment Report was circulated to all \nPRAC and CHMP members on 24 September 2019
                                                            The CHMP agreed on the consolidated List of Questions to be sent to the \napplicant during the meeting on   17 October 2019
                                                                                The applicant submitted the responses to the CHMP consolidated List of \nQuestions on     23 April 2020
The CHMP Rapporteur circulated the CHMP and PRAC Rapporteurs Joint \nAssessment Report on the applicant's responses to the List of Questions \nto all CHMP members on       2 June 2020
                                                                                                                                                during the meeting on                  
                                                                                                                                                     the applicant on                  
                                                                                                                                                Outstanding Issues on                  
                                                                                                                                                                                       
                                                                                                                                                  to the applicant on                  
                                                                                                  of Outstanding Issues on  \nM edicinal product no longer authorised                  
                                                                                                                                                                                       
                                                                                                                                                                                       
                                                                                                                                                                                       